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The murine cytomegalovirus (MCMV) monoclonal antibody 5C7:6 was used in Western analysis to probe MCMV infected
murine embryo cells (MEC). This antibody recognizes three virus specific polypeptides of 130, 105, and 95 kDa and
pulse–chase experiments demonstrated that these three proteins, although antigenically related, are distinct. The 105- and
95-kDa species were expressed with early kinetics, whereas the 130-kDa protein was synthesized as a true late. By screening
a lgt11 MCMV cDNA library, the gene encoding these proteins was identified as the M25 open reading frame previously
reported by Dallas et al. (Dallas, P. B., Lyons, P. A., Hudson, J. B., Scalzo, A. A., and Shellam, G. R., 1994, Virology 200, 643–650).
Immunofluorescent studies monitored the location of pM25, present in the nucleus at 15 h after infection, condensing around
the periphery of the nucleus at 18 h, before finally accumulating in the cytoplasm. Immunoelectron microscopy detected gold
particles associated with the viral tegument of enveloped virions located in the cytoplasm and extracellular space but not
with naked nucleocapsids. Western analysis of MCMV purified virions depicted the presence of the 130-kDa protein, the
predominant M25 species, in mature virus particles. Together these findings provide compelling evidence that the 130-kDa
M25 polypeptide is a component of the viral tegument. © 1999 Academic Press
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Located between the nucleocapsid and outer enve-
ope of all herpesviruses is an asymmetric region called
he tegument. In human cytomegalovirus (HCMV), the
rotein composition of the tegument is ill defined but is
stimated to be composed of 20–25 proteins, many of
hem modified by phosphorylation (reviewed Mocarski,
993; Spaete et al., 1994). These proteins are derived
rom both viral and cellular origins and may play a critical
ole in the regulation of viral gene expression as well as
iral maturation and egress (Gibson, 1983; Liu and Stin-
ki, 1992; Baldick and Shenk, 1996; Meyer et al., 1997).
The most extensively studied HCMV tegument pro-
eins include the gene products of the UL32 (pp150 or
ajor basic phosphoprotein), UL82 (pp71 or upper matrix
rotein), and UL83 (pp65 or lower matrix protein) open
eading frames (ORFs). ppUL32 comprises 20% of the
otal virion mass (Gibson, 1983) and may play a role in
he transport of DNA-filled capsids through the nuclear
nvelope or stabilization of nucleocapsids in the cyto-
lasm (Meyer et al., 1997). ppUL82 functions as a trans-
ctivator, enhancing transcription from promoters con-
aining ATF and AP-1 binding sites (Liu and Stinski, 1992).
ncluded as a ppUL82 target is the HCMV major imme-
1 To whom reprint requests should be addressed at Division of
nfectious Diseases, University of Connecticut Health Center, Farming-aon, CT 06030-3212. Fax: (860) 679-4701. E-mail: cawu@nso1.uchc.edu.
265iate early (MIE) promoter, and regulation of MIE gene
xpression is thought to be a central point in controlling
oth lytic and latent infection. In addition to its role as a
ransactivator, ppUL82 also enhances viral replication
nd viral spread (Baldick et al., 1997). The rapid transport
f ppUL83 to the nucleus in the absence of viral gene
xpression suggests a role for this protein in the initia-
ion of viral infection (Yamauchi et al., 1985; Geballe et al.,
986; Britt and Vugler, 1987; Grefte et al., 1992). However,
lthough ppUL83 exhibits protein kinase activity (Somo-
yi et al., 1990), it is not essential for virus growth in vitro
Schmolke et al., 1995).
Murine cytomegalovirus (MCMV) has proven a useful
odel system for investigating HCMV pathogenesis. The
pparent MCMV homologues of the HCMV UL82 and
L83 proteins have been described (Cranmer et al.,
996), and other potential MCMV tegument proteins have
een tentatively identified by DNA sequence homology
Rawlinson et al., 1996). In an effort to identify and further
haracterize MCMV proteins located within the tegu-
ent, we have examined the kinetic expression of the
25 open reading frame (ORF), first described by Dallas
t al. (1994). Western analysis demonstrates that this
ene encodes at least three distinct, yet antigenically
elated, polypeptides that are expressed with different
emporal kinetics. All three proteins are present in both
he nucleus and cytoplasm of infected cells in different
elative abundance. Western analysis of purified virions
nd immuno-electron microscopy (EM) studies provide
0042-6822/99 $30.00
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266 WU ET AL.he first direct evidence that the 130-kDa M25 protein is
ndeed a component of the viral tegument.
RESULTS
haracterization of the 5C7:6 monoclonal antibody
A series of monoclonal antibodies were generated
gainst MCMV and screened for their ability to neutralize
he virus in an assay developed by Gonczol et al. (1986).
s shown in Table 1, sera obtained from a MCMV im-
une mouse and monoclonal antibodies specific for
CMV glycoprotein H (IE8 and 4B6) were capable of
irus neutralization. A modest reduction in viral titer was
onsistently noted for normal mouse serum in this assay.
n contrast, monoclonal antibody 5C7:6, as well as mono-
lonal antibodies 25G11 and 16F7, which are specific for
he MCMV DNA polymerase accessory protein and
CMV glycoprotein B, respectively, exhibited no neutral-
zing activity. In addition, injection of mice with 5C7:6
ntibody did not afford protection upon challenge with a
ublethal dose of virus (data not shown).
dentification of MCMV cDNA clones that react with
he 5C7:6 antibody
To identify the gene encoding the protein recognized
y the 5C7:6 monoclonal antibody, a lgt11 MCMV cDNA
xpression library was constructed. Upon screening,
everal immunoreactive clones were recognized, and
lasmid pCH5C7b, which contained the largest insert,
as chosen for use in the mapping studies. An EcoRI
CMV cosmid library was examined, and pCH5C7b hy-
ridized exclusively with EcoRI fragment C (Fig. 1). This
inding was confirmed by Southern analysis of MCMV
enomic DNA digested with EcoRI or HindIII. Subse-
uent restriction endonuclease mapping studies identi-
ied a 2.2-kb Tth111 I fragment. Determination of its DNA
equence revealed that this fragment contains 1.7 kb of
he carboxyl-terminus of the M25 ORF reported by Dallas
TABLE 1
Neutralization Activity of the 5C7:6 Monoclonal Antibody
Antibody/Antiserum Plaquesa
Viral plaques
(Percent control)
one 77.5 6 9.3 100
ormal mouse 53.5 6 6.1 69
CMV immune mouse 1.0 6 0.8 1
E8 0 0
B6 5.3 6 1.7 7
C7:6 75.3 6 8.5 97
5G11 74.3 6 2.9 96
6F7 74.3 6 2.6 96
a Plaque numbers were calculated from the average of four individual
ultures 6 the standard deviation as determined by a Student’s t-test.t al. (1994) as well the carboxyl-terminus of the m25.1 rRF positioned on the complementary DNA strand (Raw-
inson et al., 1996). To verify which ORF reacted with the
C7:6 antibody, the DNA sequence of the pCH5C7b
robe was determined. This sequence corresponded
ith the M25 gene, beginning at map position 28,958 in
he middle of the ORF and ending at position 28,948, 10
ases downstream from the polyadenylation signal.
xpression of the M25 ORF
To investigate the kinetics of M25 gene expression,
CMV-infected MEC cultures were harvested at 3-h in-
ervals over a 24-h period and processed for Western
nalysis using the monoclonal antibody 5C7:6 as a
robe. Cell cultures were treated with trypsin immedi-
tely after infection to remove residual inoculum and
ermit examination of de novo protein synthesis. As
hown in Fig. 2, the appearance of a virus specific
rotein was first observed at 9 h after infection (lane 4).
he size of this protein, 105 kDa, is in agreement with the
redicted size of a protein encoded by the M25 ORF,
03.2 kDa. At 15 h after infection, two other proteins of
30 and 95 kDa were observed (Fig. 2, lane 6). The
30-kDa polypeptide became the predominate species
s infection continued (Fig. 2, lane 9). As a negative
ontrol, Western blots of MCMV-infected MEC cultures
ere probed with an isotype-matched, irrelevant mono-
lonal antibody and no signal was detected.
The kinetics of expression of the 105- and 130-kDa
olypeptides was consistent with the hypothesis that
hese proteins might exist in a precursor-product rela-
ionship. Furthermore the appearance of the 95-kDa pro-
ein coincided with the synthesis of the 130-kDa species,
aising the possibility that this protein could be a cleav-
ge or proteolytic degradation product. To address these
ssues, pulse–chase experiments were performed using
he 5C7:6 monoclonal antibody to precipitate the proteins
f interest. Based on the results of the Western analysis
n Fig. 2, two time points were chosen for examination,
h when only the 105-kDa species was evident and 16 h
hen all three proteins were observed. As shown in Fig.
, immunoprecipitation of proteins isolated from MCMV-
nfected MEC labeled at 9 h after infection indicated the
resence of both the 105- and 95-kDa polypeptides (lane
). This result differs from the data obtained by Western
nalysis (Fig. 2, lane 4). Upon a chase to 20 h after
nfection in the presence of excess cold methionine, no
hange in the protein profile was noted (lane 3). Immu-
oprecipitation of proteins from MCMV-infected MEC
abeled at 16 h demonstrated the presence of the 130-,
05-, and 95-kDa polypeptides (lane 5). The relative ratio
f these three proteins remained constant upon a chase
o 20 h after infection (lane 6). In addition, a minor, faster
igrating band of ;70 kDa was also apparent upon
hase (lane 6, denoted by an asterisk) and most probably
epresents a degradation product as it was not present
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267MCMV M25 TEGUMENT PROTEINn the pulse. These results denote two important points.
irst, there is no evidence of a precursor-product rela-
ionship between the 105- and 130-kDa proteins. Second,
FIG. 1. Identification of the MCMV gene encoding the protein recogn
ubcloning strategy employed in identifying a 2.2-kb Tth111 I fragment
nder Methods and Materials. Also shown here is the BamHI–KpnI fra
FIG. 2. Kinetic expression of pM25. Uninfected (lane 1) or MCMV
nfected (lanes 2–9) MEC cultures were harvested at the indicated time
oints and examined by Western analysis using the 5C7:6 monoclonal
ntibody. The arrows indicate the position of the 130-, 105-, and 95-kDa
pecies of pM25. Identical protein samples were electrophoresed
hrough a SDS–polyacrylamide gel and stained with Coomassie bril-
iant blue to confirm that equal amounts of protein were loaded for eachpime point (data not shown).ecause the 95-kDa species was synthesized before the
30-kDa polypeptide and its abundance does not in-
rease over time, it can not be a degradation product.
hese findings suggest that expression from the M25
RF results in the synthesis of multiple protein products.
he M25 ORF appears to encode the 130-, 105-, and
5-kDa polypeptides
To address the possibility that all three polypeptides
ecognized by the 5C7:6 monoclonal antibody are en-
oded by the M25 ORF, the following experiment was
erformed. Transient expression of pMC302, an expres-
ion vector containing the entire M25 ORF, was exam-
ned in Vero cells. As shown in Fig. 4, expression of this
lasmid resulted in the generation of four novel proteins
lane 2) not present in cells transfected with vector alone
lane 1). Based on electrophoretic mobility, the apparent
olecular weights of the three largest polypeptides were
35, 105, and 94 kDa, similar to the results obtained with
CMV-infected MEC. Furthermore, the relative abun-
ance of these three proteins was similar to the pattern
f pM25 expression observed in infected cells. A fourth
the 5C7:6 monoclonal antibody. This schematic diagram outlines the
ntains a portion of the M25 open reading frame as described in detail
used in the construction of pMC302 (Fig. 4).ized by
that corotein, 53 kDa in size, may represent a unique protein
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268 WU ET AL.ot previously observed in MCMV-infected MEC cultures
r a proteolytic degradation product. This data support
he idea that the M25 ORF encodes three antigenically
elated protein products.
FIG. 3. The 130-, 105-, and 95-kDa M25 proteins are distinct, yet
ntigenically related polypeptides. Uninfected (lanes 1 and 4) and
CMV-infected (lanes 2, 3, 5, and 6) MEC cultures were pulse labeled
n the presence of 35[S]methionine between 8 and 9 h (lanes 1–3) or 15
nd 16 h (lanes 4–6) after infection, then chased (lanes 3 and 6) in the
resence of excess cold methionine. M25 proteins were immunopre-
ipitated with the 5C7:6 monoclonal antibody and analyzed by SDS–
AGE. The arrows indicate the position of the 130-, 105-, and 95-kDa
25 proteins. *, a novel protein detected only upon chase late in
nfection (lane 6).
FIG. 4. The M25 ORF appears to encode multiple proteins. Vero cells
ere transfected with the construct pMC302 which contains the M25
RF as well as the carboxyl-terminus of the m25.1 ORF on the com-
lementary DNA strand (lane 2). Vector pcDNA3.1(2) was introduced
nto cells as a negative control (lane 1). After 24 h, cell lysates were
arvested and examined by Western analysis using the 5C7:6 mono-
lonal antibody. The arrows represent proteins of 135, 105, 94, and 53iDa that are present only in cells transfected with pMC302.lassification of M25 proteins based on kinetic
xpression
To monitor the synthesis of the M25 proteins with
espect to the replicative cycle of MCMV, Western anal-
sis using the 5C7:6 monoclonal antibody was per-
ormed on MCMV-infected cell lysates exposed to vari-
us metabolic inhibitors (Fig. 5). Treatment with phos-
honoformic acid (PFA or Foscarnet), a potent inhibitor of
iral DNA replication, blocked the synthesis of the 130-
Da polypeptide (Fig. 5A, compare lanes 3 and 4). In
ontrast, treatment with PFA for 24 (lane 4) or 48 h (lane
) did not abolish the production of the 105- and 95-kDa
roteins. Identical results were obtained after treatment
ith acyclovir, another inhibitor of viral DNA synthesis
data not shown). Together, these results suggest that
he 130-kDa protein is expressed as a true late, whereas
he 105- and 95-kDa M25 polypeptides are synthesized
ith early kinetics.
ocalization of pM25 within the infected cell
To determine the intracellular location of pM25, protein
xpression was monitored by indirect immunofluores-
ence using the 5C7:6 monoclonal antibody. Expression
f pM25 was first observed 12 h after infection and at this
arly stage, between 12 and 15 h, the nucleus of infected
EC exhibited a strong punctate pattern (Fig. 6A). Min-
mal staining of the cytoplasm was observed. At 18 h
fter infection, the M25 proteins were condensed around
he periphery of the nucleus (Fig. 6B). By 24 h after
FIG. 5. Treatment with viral DNA replication inhibitors abolishes the
ynthesis of the 130-kDa M25 protein. MEC monolayers were mock
nfected (lane 1) or infected with MCMV (lanes 2–5) in the absence
lanes 1–3) or presence of phosphonoformic acid (PFA) (lanes 4–5). The
ultures were harvested at the indicated times and examined by West-
rn analysis with the 5C7:6 monoclonal antibody. The arrows indicate
he position of the 130-, 105-, and 95-kDa species of pM25. To verify that
qual amounts of protein were loaded into each well, identical samples
ere electrophoresed through a SDS–polyacrylamide gel and visual-
zed with Coomassie brilliant blue (data not shown).nfection, the staining pattern for pM25 again changed
d
d
p
s
o
b
t
a
(
t
t
a
M
y
t
b
k
i
m
M
c
M
f
269MCMV M25 TEGUMENT PROTEINramatically. Immunofluorescence appeared to be pre-
ominately cytoplasmic in nature, with the majority of
M25 concentrated in aggregates (Fig. 6C). Little nuclear
taining was observed. In all three panels, the specificity
f the primary and secondary antibodies was evident
y the absence of reactivity of uninfected MEC within
he monolayer. In addition, no staining was noted with
n isotype matched, irrelevant monoclonal antibody
Fig. 6D).
FIG. 6. Intracellular localization of pM25 at different times after MCM
nfection over 24-h period and analyzed by indirect immunofluorescence
onoclonal antibody (D). Shown here are 15-h (A), 18-h (B), and 24-h (C
agnification, 3800.
FIG. 7. Comparison of nuclear and cytoplasmic fractions of MCMV
ultures were harvested at the indicated time points and separated
aterials. MCMV-encoded proteins were visualized by Western analysior pM25, the DNA polymerase accessory protein, and glycoprotein B, respecThe 5C7:6 antibody recognizes three distinct polypep-
ides of 130, 105, and 95 kDa (Fig. 3). To further interpret
he results obtained in Fig. 6, nuclear (nuclear matrix)
nd cytoplasmic (soluble) fractions were prepared from
CMV-infected MEC. As shown in Fig. 7, Western anal-
sis of these fractions indicated that all three polypep-
ides were present in both the nucleus and cytoplasm
etween 18 and 24 h after infection. However, the 105-
Da protein, first observed in the nucleus at 12 h after
tion. MCMV-infected MEC monolayers were harvested every 3 h after
the 5C7:6 monoclonal antibody (A–C) or an isotype-matched, irrelevant
) time points with the phase and immunofluorescent images merged.
d cells for the presence of M25 polypeptides. MCMV-infected MEC
uclear and cytoplasmic fractions, as described under Methods and
the monoclonal antibodies 5C7:6, 25G11, and 16F7, which are specificV infec
using
and D-infecte
into n
s using
tively.
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270 WU ET AL.nfection, was the predominant species in the nucleus
ntil 24 h after infection. In contrast, the 130-kDa protein,
irst noted at 18 h, was the major species present in the
ytoplasm during the late stages of infection. Cytoplas-
ic fractions, particularly at late times of infection, ap-
eared to be susceptible to proteolytic degradation, even
hough multiple protease inhibitors were present in the
ysis buffer. Western analysis of the nuclear and cyto-
lasmic fractions was also performed with the monoclo-
al antibodies 25G11 and 16F7. These two antibodies
ecognize the MCMV DNA polymerase accessory pro-
ein (25G11) and MCMV glycoprotein B (16F7) and serve
s markers for nuclear and cytoplasmic purity, respec-
ively. Together, these results suggest that the nuclear
taining observed at early times after infection (Fig. 6A)
s representative of the 105-kDa protein, whereas the
ytoplasmic aggregates present at 21 and 24 h (Fig. 6C)
re composed predominately of the 130-kDa polypep-
ide.
he 130-kDa M25 protein is present in the tegument
The localization of M25 gene products during MCMV
eplication was examined in greater detail using immu-
ogold labeling with the 5C7:6 antibody. In the nucleus of
CMV-infected MEC, both translucent and electron
ense capsids (also referred to as type A and type B
apsids, respectively) were observed (Fig. 8A). These
tructures represent various stages of nucleocapsid
aturation, but neither reacted with the 5C7:6 antibody.
nstead, pM25 was localized in electron dense amor-
hous material that was not present in uninfected cells.
ndividual virions and multicapsid structures were
resent in the cytoplasm (Fig. 8B). Multicapsid virions
ontain an average of 2–20 capsids enveloped by a
ingle membrane and are a distinguishing feature of
CMV infection (Hudson et al., 1976). Immunogold was
onsistently localized to both single and multicapsid
irions, and the staining pattern was associated with the
iral tegument, being located externally to the nucleo-
apsid structure (Fig. 8B). This was also true for mature
irions found extracellularly (Fig. 8C). Immunogold was
ccasionally found associated with the Golgi apparatus
n the absence of viral structures. Staining was not ob-
erved in uninfected MEC or in MCMV-infected MEC
amples in the absence of 5C7:6 antibody. Thus we
onclude that at least one M25 polypeptide is a compo-
ent of the MCMV tegument.
To identify which M25 polypeptide(s) was present in
he tegument, Western analysis of purified virions was
erformed (Fig. 9). As shown in lane 1, the 130-kDa M25
rotein was detected in mature MCMV virus particles.
owever, no compelling evidence for the presence of the
5- or 105-kDa protein was noted. At this time, it is not
lear whether the early M25 proteins are absent from the
iral tegument or beyond the limits of detection in this nssay. In contrast, all three M25 proteins were present in
CMV-infected MEC harvested at the same time (lane
). Thus it was concluded that the most abundant M25
rotein, the 130-kDa species, is a component of the
egument.
DISCUSSION
The components of the viral tegument are uniquely
ositioned to play a significant role in multiple stages of
he viral pathway, including regulation of IE gene expres-
ion and particle maturation and egress. The limited
nformation available on the composition of the MCMV
egument is based largely on shared genomic colinearity
nd DNA sequence homology with HCMV. In the studies
escribed, we have characterized the gene products of
he MCMV M25 ORF, demonstrating that this gene en-
odes three distinct proteins, at least one of which is
ocated within the viral tegument.
The M25 gene first was identified by Dallas et al.
1994); however, the monoclonal antibody used in their
tudies was cross-reactive with host cell proteins, thus
estricting their analysis (Farrell and Shellam, 1990). Uti-
izing a different monoclonal reagent of higher specificity,
e have shown by immunoelectron microscopy that
M25 is associated with the tegument of multicapsid and
ingle-capsid virions located within the cytoplasm and
xtracellular space of infected monolayers, but not with
aked nucleocapsids (Fig. 8). Western analysis of puri-
ied virions demonstrated that the most abundant M25
rotein, the 130-kDa species, was present in virus parti-
les (Fig. 9), and on the basis of its sensitivity to DNA
eplication inhibitors, this protein was classified as a true
ate (Fig. 5). These findings are in agreement with studies
f HCMV pUL25, the homologue of MCMV pM25. Baldick
nd Shenk (1996) examined the protein composition of
urified HCMV virions and, through amino acid se-
uence analysis, identified the presence of the UL25
ene product in mature particles and dense bodies.
sing confocal and immunoelectron microscopy tech-
iques, Zini et al. (1999) have confirmed these earlier
indings. Furthermore the expression of the HCMV UL25
RF was shown to occur with late kinetics (Battista et al.,
999).
In addition to the 130-kDa late protein, the M25 ORF
ncoded two other polypeptides of 105 and 95 kDa that
re expressed with early kinetics. Pulse–chase experi-
ents (Fig. 3) confirmed that although all three share a
ommon antigenic site, these proteins are distinct. Mul-
iple promoters differentially regulating a single gene
ave been described for other herpesviruses (Hall et al.,
982; Draper et al., 1986; Chang et al., 1989) but was not
ound to be characteristic of HCMV UL25 gene expres-
ion. The MCMV M25 ORF is 2796 nucleotides in length,
ignificantly larger than the HCMV UL25 ORF of 1968
ucleotides (Chee et al., 1990; Rawlinson et al., 1996).
i
p
m
271MCMV M25 TEGUMENT PROTEINFIG. 8. Ultrastructural localization of pM25 by immuno-electron microscopy. MCMV-infected MEC were harvested at 24 h and labeled with
mmunogold using the 5C7:6 monoclonal antibody. Representative thin sections depict the nucleus (A), cytoplasm (B), and extracellular space (C).
M25 was associated with patches of amorphous electron dense material in the nucleus but not nucleocapsids (A), as well as with enveloped
ulticapsid and single-capsid virions present in the cytoplasm (B) and extraceullular space (C). Bar scale 5 0.5 mm.
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272 WU ET AL.LAST alignment of the predicted proteins encoded by
hese two genes shows 26% identity at the amino acid
evel. However, this shared homology is not dispersed
hroughout the MCMV M25 protein but restricted to the
arboxyl-terminus from amino acids 494 to 880. This
uggests that functional differences may exist between
he gene products of the HCMV UL25 and MCMV M25
RFs.
Northern analysis performed by Dallas et al. (1994)
dentified a single 3-kb M25 transcript expressed late in
nfection. S1 nuclease studies mapped the position of
he 59 end of this mRNA to lie ;20 bp upstream of a
trong consensus TATA box positioned 148 nucleotides
ithin the M25 ORF (Dallas et al., 1994). Located down-
tream of the predicted start site of translation is a
otential downstream activation sequence (DAS). This
ignal, ACCG(T/A)C, is repeated three times within the
irst 50 nucleotides of the predicted translated region,
lthough it is the position, not the actual sequence, that
s thought to be critical for function. Direct evidence
upporting the importance of these signals in M25 late
ene expression is lacking, but similar elements are
haracteristic of HSV-1 late promoters (Wagner et al.,
995). Based on this information, we hypothesize that the
25 late promoter lies within the M25 ORF and is re-
ponsible for regulating the synthesis of the 3-kb late
RNA and the 130-kDa M25 protein.
In an attempt to identify potential early promoters, the
NA sequence 600 nucleotides upstream from the start
f the M25 ORF was examined for the presence of TATA
oxes and binding sites of known eukaryotic transcrip-
ional factors (ATF, NF- 75 B, AP-1, SRE, and SP-1 sites).
o significant TATA box motifs were found; however,
ultiple potential SP-1 sites were located from 27 to
250. SP-1 appears to be critical for the activation of the
FIG. 9. Comparison of M25 proteins present in MCMV-infected cells
nd purified virions. Total protein from MCMV-infected CD-1 cells (lane
) and gradient purified MCMV virus particles (lane 1) were examined
y Western analysis using the 5C7:6 monoclonal antibody. The arrows
ndicate the positions of the 130-, 105-, and 95-kDa M25 polypeptides.CMV UL54 (DNA polymerase) early promoter (Kerry et Ul., 1996), and SP-1 has been shown to drive transcription
rom TATA-less promoters (Swick et al., 1989; Blake et al.,
990). Preliminary RT–PCR experiments have detected a
25 mRNA that hybridizes with the start of the M25 ORF
nd the transcription of which appears to be regulated by
n early promoter (Wu, unpublished results). The ability
f Dallas et al. (1994) to detect only a single late tran-
cript from total RNA suggests that the M25 early mRNAs
ay be present in low abundance. To overcome this
roblem, studies are currently underway to examine M25
ene expression by isolating mRNA from MCMV-infected
ells.
Much controversy still surrounds the pathway of en-
elopment and egress of herpesvirus particles, including
he precise cellular location of tegument assembly. A
ecent report by Sanchez et al. (1998) characterized a
irect interaction between the HCMV tegument protein
L83 and the lamin proteins of the nuclear matrix. In this
tudy, ppUL83 was compartmentalized in the nucleus,
ccumulating along the periphery. Ward et al. (1996)
escribed the aggregation of capsid proteins surround-
ng the periphery of the nucleus in herpes simplex virus-
nfected cells. These structures, termed assemblons, are
ypothesized to be involved in capsid assembly and
ave been shown to contain tegument proteins. Our
mmunofluorescent studies (Fig. 6) have depicted the
resence of M25 proteins in the nucleus during early
tages of infection, followed by aggregating around the
ucleus, and finally accumulating in the cytoplasm dur-
ng the late phase of infection. All three M25 proteins are
resent in both the nucleus and cytoplasm of infected
ells, albeit in different relative abundance. In contrast,
CMV UL25 expression was restricted solely to the
ytoplasm (Battista et al., 1999). Immunofluorescent ex-
mination of HCMV tegument proteins UL82 and UL83
evealed a staining pattern that mimics MCMV pM25,
eing present in the nucleus at early times after infec-
ion, but changing dramatically with time. By 48 h after
nfection, the nuclear staining diminished and cytoplas-
ic immunofluorescence appeared to be condensed
nto “cap-like” structures (Hensel et al., 1995, 1996). A
imilar concentration of cytoplasmic staining also was
eported for HCMV tegument protein UL32 (Hensel et al.,
995). It is tempting to speculate that this consolidation
f tegument proteins around the nucleus and in the
ytoplasm is important for the acquisition of tegument
uring particle maturation.
On the basis of the predicted amino acid sequence
omology, Chee et al. (1990) identified HCMV UL25 as
art of a two-member gene family composed of UL25
nd UL35. A similar family is encoded by MCMV (Raw-
inson et al., 1996), making these proteins unique to
etaherpesviruses. Interestingly, human herpesvirus-6
nd human herpesvirus-7, two recently discovered beta-
erpesviruses, encode either a homologue of HCMV
L25 or UL35, but not both (Gompels et al., 1995; Nich-
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273MCMV M25 TEGUMENT PROTEINlas, 1996; Stefan et al., 1997). The biological function of
his gene family is unknown and the results presented
ere represent an important first step in unraveling this
uzzle.
METHODS AND MATERIALS
ells and virus
Mouse embryo cells (MEC) were prepared from em-
ryos of late-term pregnant CD-1 mice by trypsin-EDTA
isaggregation and maintained in tissue culture using
ulbecco’s modified Eagle’s medium (DMEM) containing
0% fetal calf serum (FCS; Gemini Bio-Products), 100
nits/ml penicillin, and 50 mg/ml streptomycin. The K181
train of MCMV was propagated as previously described
Shanley et al., 1993).
roduction of monoclonal hybridomas
A series of monoclonal hybridomas generating anti-
odies against MCMV were produced by a modification
f the method of Togashi et al. (1981). Briefly, BALB/c
ice were infected by intraperitoneal injection with 1 3
04 PFU MCMV, followed by additional virus challenges
f 1 3 105 PFU at 2 and 3 months. After a 6- to 8-week
est period, the mice received a suspension of 1 3 106
CMV infected BALB/c fibroblasts. Four to 6 days later,
ice were killed, and their serum was collected to de-
ermine viral antibody titers. Spleen cells were treated
ith 0.72% ammonium chloride to remove residual red
lood cells and fused to NSO-1-Ag myeloma cells (Amer-
can Type Culture Collection, ATCC) for hybridoma pro-
uction using polyethylene glycol 1000. The hybridomas
ere selected by maintenance in HAT medium [Eagle’s
inimal essential medium (MEM) supplemented with
5% FCS (Gemini Bio-Products), 100 mM hypoxanthine,
6 mM thymidine and 0.4 mM aminopterin (all purchased
rom Sigma)].
All hybridomas (5C7:6, IE8, 4B6, 23G11, and 16F7) were
valuated for neutralizing activity using a modification of
microneutralization assay that scores for a reduction in
he number of plaques (Gonczol et al., 1986). Briefly,
CMV strain K181 was diluted to achieve 50 plaques per
ell on a 48-well plate and incubated with serial dilu-
ions of each monoclonal antibody for 1 h at 37°C. After
he addition of guinea-pig complement, incubation was
ontinued for 30 min, and this virus-antibody-comple-
ent mixture was added to monolayers of MEC for 1 h.
he cells were overlaid with 1% methyl cellulose and
ncubation continued for 4 days at 37°C before plaques
ere visualized with methylene blue. Samples were ex-
mined in quadruplicate with each antibody being as-
ayed at least twice. MCMV immune mouse serum and
ormal mouse serum served as positive and negative
ontrols, respectively. aapping the 5C7 epitope and DNA sequence
nalysis
Polyadenylated RNA, isolated from MCMV infected
EC using the Micro Fast-Track system (Invitrogen), was
sed to generate a l gt11 cDNA library (Sambrook et al.,
989). This library was screened with the 5C7:6 mono-
lonal antibody at a 1:100 dilution and 56 positive
laques were identified. Four of these plaques were
urther purified and plasmid pCH5C7b, which contained
he largest insert (1.9 kb), was used for subsequent
apping studies. An EcoRI library of MCVM strain K181,
epresenting ;60% of the total viral genome, (gift of Dr.
. Colin Jordan, Oregon Health Sciences University) was
igested with EcoRI, resolved on a 0.8% agarose gel,
ransferred to GeneScreen Plus (New England Nuclear-
upont), and hybridized with 32P-labeled pCH5C7b. Au-
oradiographic analysis revealed that this probe recog-
ized EcoRI fragment “C.” A series of EcoRI fragment C
ubclones was generated using various restriction en-
onucleases and examined by Southern analysis. The
inal subclone, a 2.2-kb Tth111 I fragment, as well as the
CH5C7b insert, were sequenced using an automated
NA sequencer (Perkin–Elmer) by the Molecular Core
acility at the University of Connecticut Health Center.
estern analysis
Approximately 1 3 106 MCMV-infected MEC cells
ere harvested at 3, 6, 9, 12, 15, 18, 21, and 24 h by
craping in 500 ml lysis buffer [50 mM Tris–HCl, pH 7.5;
50 mM NaCl; 0.1% SDS; 1% Triton-X 100; and 1 mM
henylmethylsulfonyl fluoride (PMSF)]. Proteins were re-
olved by separation through a 6% SDS–polyacrylamide
el and transferred to PVDF membranes (BioRad). An
dentical gel was stained with Coomassie brilliant blue to
ormalize the amount of protein present in each sample.
he blots were incubated with 5C7:6 monoclonal anti-
ody (1:100 dilution) and detected with an alkaline phos-
hatase-conjugated goat anti-mouse antibody (1:3000
ilution; Sigma). Immunocomplexes were visualized us-
ng NBT (nitroblue tetrazolium)– BCIP (5-bromo-4-chloro-
-indolylphosphate toluidinium) (both purchased from
igma) as the substrate. As a negative control, Western
lots of MCMV-infected MEC were probed with an iso-
ype-matched (IgG1), irrelevant monoclonal antibody
pecific for rat K-Cadherin (1:1000 dilution, Transduction
aboratories).
Expression of MCMV early proteins was examined by
ncubating MCMV-infected cell monolayers in the pres-
nce of phosphonoformic acid (PFA; Sigma) at 100
g/ml.
ulse–chase experiments
Metabolic labeling of proteins from MCMV-infected
nd -uninfected MEC was accomplished as follows. Cul-
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274 WU ET AL.ures were “starved” by incubation for 1 h at 37°C in
ethionine/cysteine free DMEM supplemented with 10%
ialyzed FCS. Incubation was continued for 1 h in similar
edium containing 300 mCi/ml of 35[S]methionine (Am-
rsham). One T-75 flask was harvested immediately
pulse), and the other flask (chase) was washed three
imes in medium and incubated in complete DMEM with
n excess of 1 mM cold methionine. At 20 h after infec-
ion, cell monolayers were washed twice in ice-cold PBS
nd collected by scraping in 0.75 ml of RIPA buffer [50
M Tris–HCl (pH 7.5), 150 mM NaCl, 1% Nonidet-P40,
.25% deoxycholic acid, 0.2% SDS, aprotinin, leupeptin,
epstatin, and PMSF].
To pre-clear the cellular lysates, 75 ml of Protein A
epharose beads (Sigma) in a 50% slurry were added to
ach sample for 30 min at 4°C. Immunocomplexes were
enerated by the addition of 25 ml of 5C7:6 monoclonal
ntibody for 2 h at 4°C, followed by the addition of 30 ml
f rabbit anti-mouse IgG (Organon Tekinika) for 2 h at
°C. Complexes were collected by incubation with Pro-
ein A Sepharose beads at 4°C for 2 h. After three
ashes with ice-cold RIPA, the protein precipitates were
nalyzed by SDS–PAGE.
onstruction of pMC302 and transfection assays
A 4.3-kb BamHI–Acc65I (KpnI) fragment was isolated
rom MCMV EcoRI fragment C and cloned into the cor-
esponding sites of the expression vector, pcDNA3.1(2)
Invitrogen). This plasmid, pMC302, contains a 19-bp
egion upstream of the M25 ORF as well as the entire
25 ORF and 583 bp of the carboxyl-terminus of the
25.1 gene on the complementary DNA strand (see Fig.
). Transfections were performed in 35-mm dishes
eeded the previous day with 2 3 105 Vero cells (ATCC).
lasmid DNA (2 mg/dish) was introduced into cells with
ml of lipofectamine (Gibco/BRL) with vector alone serv-
ng as a negative control. After 24 h, cells were harvested
n 300 ml of RIPA buffer and gene expression was ana-
yzed by Western analysis using the 5C7:6 monoclonal
ntibody.
ndirect immunofluorescent assays
The intracellular location of pM25 was examined by
ndirect immunofluorescence using the 5C7:6 monoclo-
al antibody. MEC, seeded onto cover slips, were in-
ected with MCMV at a m.o.i. of 1. At various times after
nfection (i.e., 3, 6, 9, 12, 15, 18, 21, and 24 h), cells were
ixed with 3.75% formaldehyde, permeablized with 0.5%
riton-X 100, and stained with monoclonal 5C7:6 anti-
ody at a 1:100 dilution. After three washes with PBS, the
ells were exposed to goat anti-mouse IgG conjugated
ith rhodamine (Organon Tekinika) for 1 h. After three
ashes in PBS, the coverslips were mounted in veronal
uffered glycerol, pH 8.6 (25 mM 5,5-diethylbarbituric
cid, 50 mM NaCl, and 50% glycerol) in preparation for 1hase-contrast and fluorescence analysis using a Leitz
iaplan microscope. Negative controls included unin-
ected MEC probed with 5C7:6 monoclonal antibody and
CMV- infected MEC monolayers screened with rat K-
adherin monoclonal antibody (an isotype matched, ir-
elevant reagent).
reparation of nuclear and cytoplasmic fractions
MEC were infected as described above, and two T-75
lasks were harvested for each time point at 12, 15, 18, 21,
nd 24 h after infection. Monolayers were scraped in
BS with 1% Nonidet-P40 and protease inhibitors and
entrifuged to pellet the nuclear matrix. The soluble (cy-
oplasmic) fraction was removed, and the nuclei were
ashed repeatedly in PBS before resuspension in RIPA
uffer. The protein profiles of these two fractions were
ompared by Western analysis using the 5C7:6 antibody
s a probe. The identity of these fractions was confirmed
sing monoclonal antibodies specific for the DNA poly-
erase accessory protein (25G11) and glycoprotein B
16F7), MCMV proteins that are present in the nucleus
nd cytoplasm, respectively.
urification of virions
Fourteen T-75 flasks of MEC were infected at a m.o.i.
f 5 and harvested after 24 h by scraping in PBS. This
ime point was selected due to an increase in pM25
egradation noted at later times of infection. Virus parti-
les, released after sonication, were treated with DNaseI
10 mg/ml) and collected on a 10% sucrose-TE cushion by
entrifugation at 70,000 g for 1.5 h at 15°C. The virion
ellet was resuspended in TE with protease inhibitors,
ayered on a 10 to 50% potassium tartrate gradient, and
entrifuged for 155,000 g for 1.5 h at 15°C. The resulting
irion band was extracted, dialyzed against TBS (10 mM
ris-HCl, pH 7.5, and 0.9% NaCl) overnight, and concen-
rated by methanol precipitation with glycogen at 20
g/ml (Boehringer Mannheim) acting as a carrier. The
rotein composition of the virions was determined by
estern analysis as described above.
lectron microscopy
MCMV-infected and -uninfected MEC were harvested
t 24 h and fixed for 1 h at room temperature in 3%
araformaldehyde-0.1% glutaraldehyde in 0.1 M sodium
acodylate buffer, pH 7.4. The monolayers were rinsed
nd stored briefly at 4°C in 0.1 M cacodylate buffer, pH
.4, before being embedded in 3% low-gelling agarose.
he resulting pellets were trimmed into small pieces,
ehydrated in methanol, embedded in Lowicryl K4M
esin, and polymerized under ultraviolet light at 220°C.
hin sections were cut with a diamond knife and col-
ected on Formvar-coated nickel grids. Immunogold la-
eling was performed as previously described (Hand,
995) using 5C7:6 monoclonal antibody diluted 1:50 in 1%
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275MCMV M25 TEGUMENT PROTEINSA-5% normal goat serum in PBS. Sections were exam-
ned and photographed in a Philips CM10 transmission
lectron microscope.
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